New Antiviral on the Horizon for Mild to Moderate COVID-19

COVID-19 symptoms improved 24 hours sooner among patients with mild to moderate infection who received ensitrelvir, an investigational antiviral drug, than those who received a placebo, according to results from a randomized clinical trial involving more than 1000 patients from Japan, South Korea, and Vietnam.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research